Low dose 1-hexylcarbamoyl-5-fluorouracil (HCFU) recommended for cirrhotic patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Low dose 1-hexylcarbamoyl-5-fluorouracil (HCFU) recommended for cirrhotic patients with hepatocellular carcinoma

Published:1989-08 Issue:8 Volume:25 Page:1191-1195
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Takenaka Kenji,Kanematsu Takashi,Shimada Mitsuo,Sugimachi Keizo

Publisher

Elsevier BV

Subject

Oncology

Reference20 articles.

1. Antitumor activity of carbamoyl derivatives of 5-fluorouracil by oral administration;Hoshi;Gann,1975

2. Metabolic fate of 1-hexylcarbamoyl-5-fluorouracil and 5-fluorouracil in mice bearing ascites sarcoma 180;Iigo;JNCI,1981

3. Metabolic fate of 1-hexylcarbamoyl-5-fluorouracil in rats;Kobari;Xenobiotica,1978

4. Characteristic pharmacodynamics of 1-hexylcarbamoyl-5-fluorouracil metabolism in cirrhotic patients with hepatocellular carcinoma;Watanabe;Curr Ther Res,1984

5. Role of uridine phosphorylase for anti-tumor activity of 5′-deoxy-5-fluorouridine;Ishituka;Gann,1980

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Versatile use of Carmofur: A comprehensive review of its chemistry and pharmacology;Drug Development Research;2022-08-28

2. Fluorine-Containing Diazines in Medicinal Chemistry and Agrochemistry;Fluorine in Heterocyclic Chemistry Volume 2;2014

3. Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma;British Journal of Surgery;1996-03

4. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma;The American Journal of Surgery;1995-04